Chloé Morel

1.2k total citations
35 papers, 788 citations indexed

About

Chloé Morel is a scholar working on Molecular Biology, Genetics and Small Animals. According to data from OpenAlex, Chloé Morel has authored 35 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Genetics and 6 papers in Small Animals. Recurrent topics in Chloé Morel's work include Animal health and immunology (6 papers), Reproductive Physiology in Livestock (5 papers) and Autism Spectrum Disorder Research (3 papers). Chloé Morel is often cited by papers focused on Animal health and immunology (6 papers), Reproductive Physiology in Livestock (5 papers) and Autism Spectrum Disorder Research (3 papers). Chloé Morel collaborates with scholars based in France, Switzerland and Canada. Chloé Morel's co-authors include H.M. Hammon, Y. Zbinden, C. Philipona, J.W. Blum, J. W. Blum, M. Reist, S.N. Sauter, D. von Euw, N. Kuenzi and D. Erdin and has published in prestigious journals such as PLoS ONE, Cell Metabolism and Current Biology.

In The Last Decade

Chloé Morel

34 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chloé Morel France 14 305 218 197 141 111 35 788
M. Piechotta Germany 21 539 1.8× 310 1.4× 311 1.6× 79 0.6× 115 1.0× 65 1.1k
Torsten Viergutz Germany 21 333 1.1× 253 1.2× 76 0.4× 64 0.5× 398 3.6× 76 1.3k
Barbara Jana Poland 18 307 1.0× 141 0.6× 45 0.2× 26 0.2× 85 0.8× 92 965
G. Peeters Belgium 17 362 1.2× 161 0.7× 80 0.4× 160 1.1× 171 1.5× 86 922
Beran Yokuş Türkiye 16 130 0.4× 83 0.4× 45 0.2× 103 0.7× 69 0.6× 41 880
E. Søndergaard Denmark 24 106 0.3× 233 1.1× 478 2.4× 166 1.2× 118 1.1× 67 1.7k
Michelle Garcia United States 13 249 0.8× 224 1.0× 26 0.1× 129 0.9× 126 1.1× 24 935
G Wu Canada 16 101 0.3× 99 0.5× 28 0.1× 165 1.2× 377 3.4× 31 1.1k
S. Regodón Spain 16 84 0.3× 93 0.4× 50 0.3× 43 0.3× 138 1.2× 43 597
Huatao Chen China 23 118 0.4× 134 0.6× 34 0.2× 61 0.4× 276 2.5× 69 1.1k

Countries citing papers authored by Chloé Morel

Since Specialization
Citations

This map shows the geographic impact of Chloé Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloé Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloé Morel more than expected).

Fields of papers citing papers by Chloé Morel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chloé Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloé Morel. The network helps show where Chloé Morel may publish in the future.

Co-authorship network of co-authors of Chloé Morel

This figure shows the co-authorship network connecting the top 25 collaborators of Chloé Morel. A scholar is included among the top collaborators of Chloé Morel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chloé Morel. Chloé Morel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morel, Chloé, Isabelle Gallais, Benoı̂t Pouyatos, et al.. (2025). Early stage of metabolic dysfunction associated steatotic liver disease disrupts circadian rhythm and induces neuroinflammation in rats. Scientific Reports. 15(1). 10616–10616. 2 indexed citations
2.
Morel, Chloé, et al.. (2024). The overlooked toxicity of non-carcinogenic polycyclic aromatic hydrocarbons. Environmental Chemistry Letters. 22(4). 1563–1567. 8 indexed citations
3.
Asencio, Corinne, Pauline Morand, Chloé Morel, et al.. (2024). Streptococcus pyogenes Cas9 ribonucleoprotein delivery for efficient, rapid and marker‐free gene editing in Trypanosoma and Leishmania. Molecular Microbiology. 121(6). 1079–1094. 4 indexed citations
4.
Morel, Chloé, Sophie B. Mériaux, Radu Corneliu Duca, et al.. (2023). The epigenetic hallmark of early-life α-hexabromocyclododecane exposure: From cerebellar 6-mA levels to locomotor performance in adulthood. Environment International. 178. 108103–108103. 1 indexed citations
5.
Morel, Chloé, Claude Emond, Emilie M. Hardy, et al.. (2023). Pharmacokinetic characterisation of a valproate Autism Spectrum Disorder rat model in a context of co-exposure to α-Hexabromocyclododecane. Environmental Toxicology and Pharmacology. 105. 104343–104343. 3 indexed citations
7.
Carucci, Cristina, Chloé Morel, Sabrina Bichon, et al.. (2020). Wireless In Vivo Biofuel Cell Monitoring. IEEE Journal of Electromagnetics RF and Microwaves in Medicine and Biology. 5(1). 25–34. 11 indexed citations
8.
Rémy, Murielle, Chloé Morel, Reine Bareille, et al.. (2020). New injectable self-assembled hydrogels that promote angiogenesis through a bioactive degradation product. Acta Biomaterialia. 115. 197–209. 21 indexed citations
9.
Pons‐Tostivint, Elvire, Laëtitia Daubisse‐Marliac, Pascale Grosclaude, et al.. (2019). Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care: A French regional multicenter study. The Breast. 46. 170–177. 13 indexed citations
10.
Delbès, Anne-Sophie, Julien Castel, R Denis, et al.. (2018). Prebiotics Supplementation Impact on the Reinforcing and Motivational Aspect of Feeding. Frontiers in Endocrinology. 9. 273–273. 28 indexed citations
12.
Allenspach, Karin, Edgar Ontsouka, Frédéric Gaschen, et al.. (2005). Abundance of mRNA of Growth Hormone Receptor and Insulin‐Like Growth Factors‐1 and ‐2 in Duodenal and Colonic Biopsies of Dogs with Chronic Enteropathies*. Journal of Veterinary Medicine Series A. 52(10). 491–497. 10 indexed citations
13.
Morel, Chloé, et al.. (2005). Ontogenetic development of mRNA levels and binding sites of hepatic β-adrenergic receptors in cattle. Domestic Animal Endocrinology. 28(3). 320–330. 15 indexed citations
14.
Gropp, Felix, et al.. (2005). Nuclear receptor and target gene mRNA abundance in duodenum and colon of dogs with chronic enteropathies. Domestic Animal Endocrinology. 31(4). 327–339. 9 indexed citations
15.
Morel, Chloé, et al.. (2004). Effects of dexamethasone and colostrum feeding on mRNA levels and binding capacities of β-adrenergic receptors in the liver of neonatal calves. Domestic Animal Endocrinology. 28(3). 257–271. 11 indexed citations
16.
Hammon, H.M., S.N. Sauter, M. Reist, et al.. (2003). Dexamethasone and colostrum feeding affect hepatic gluconeogenic enzymes differently in neonatal calves1,2,3. Journal of Animal Science. 81(12). 3095–3106. 61 indexed citations
17.
Sauter, S.N., C. Philipona, Chloé Morel, et al.. (2003). Intestinal Development in Neonatal Calves: Effects of Glucocorticoids and Dependence on Colostrum Feeding<sup>1</sup>. Neonatology. 85(2). 94–104. 43 indexed citations
18.
Reist, M., D. Erdin, D. von Euw, et al.. (2002). Estimation of Energy Balance at the Individual and Herd Level Using Blood and Milk Traits in High-Yielding Dairy Cows,. Journal of Dairy Science. 85(12). 3314–3327. 206 indexed citations
19.
Morel, Chloé, et al.. (2002). Physiological traits in preterm calves during their first week of life. Journal of Animal Physiology and Animal Nutrition. 86(5-6). 185–198. 21 indexed citations
20.
Hammon, H.M., et al.. (2000). Growth performance, metabolic and endocrine traits, and absorptive capacity in neonatal calves fed either colostrum or milk replacer at two levels.. Journal of Animal Science. 78(3). 609–609. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026